Bunkerhill Abdominal Aortic Quantification (AAQ) vs AI-CVD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill Abdominal Aortic Quantification (AAQ)

by BunkerHill Health

AI-CVD

by HeartLung AI

AI Verdict

Tool A, Bunkerhill Abdominal Aortic Quantification (AAQ), is highly specialized in automating abdominal aortic diameter quantification for early aneurysm detection and streamlined follow-up workflows. In contrast, Tool B, AI-CVD, offers a broader opportunistic screening platform for cardiovascular and multisystem diseases, encompassing measurements like coronary artery calcium scoring, cardiac chamber volumetry, and general aorta sizing. While both leverage AI for opportunistic screening from existing CT scans, their primary focus areas for cardiovascular assessment are distinct.

Choose Bunkerhill Abdominal Aortic Quantification (AAQ) if…

Choose Bunkerhill Abdominal Aortic Quantification (AAQ) if your primary focus is automated, precise quantification of abdominal aortic diameter for early aneurysm detection and streamlined, guideline-based follow-up workflows. This tool is ideal for organizations looking to integrate aneurysm surveillance directly into their clinical reasoning platform for automated next steps and actions.

View Bunkerhill Abdominal Aortic Quantification (AAQ) →

Choose AI-CVD if…

Choose AI-CVD if you need a comprehensive opportunistic screening platform to detect a broad range of cardiovascular and multisystem disease risks from existing chest and abdominal CT scans. This solution is best suited for identifying multiple pathologies, including coronary artery calcium, valve calcification, and cardiac chamber abnormalities, without requiring additional imaging or workflow disruption.

View AI-CVD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill Abdominal Aortic Quantification (AAQ)	AI-CVD
Pricing	Contact for pricing	Unknown
Deployment	Cloud-based (utilizes AWS for cloud infrastructure)	Unknown
FDA Status	Yes AI-estimated	Unknown
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill Abdominal Aortic Quantification (AAQ)

Tool A emphasizes 'seamless integration with Electronic Health Records (EHRs)' and 'automation of appropriate next steps and actions within clinical workflows,' suggesting a deeper integration into existing clinical processes. While Tool B highlights 'no additional imaging, radiation, contrast, or workflow disruption,' Tool A's focus on automated follow-up and EHR integration points to a more comprehensive enhancement of the user's workflow.

Clinical Value

AI-CVD

Tool B offers a broader range of opportunistic screening capabilities, including Coronary Artery Calcium (CAC) scoring, aortic valve analysis, cardiac chamber volumetry, and epicardial fat volumetry, addressing multiple cardiovascular and multisystem diseases. Tool A is highly specialized in abdominal aortic diameter quantification for aneurysm detection. While both provide significant clinical value, Tool B's wider array of measurements from a single scan offers a more comprehensive risk assessment.

Pricing & Value

Tie

Both tools require direct contact for pricing, with Tool A explicitly stating 'custom pricing based on deployment and features.' Without transparent pricing structures or publicly available ROI data for either product, it is impossible to determine which offers better value or a more favorable pricing model.

Enterprise Readiness

Bunkerhill Abdominal Aortic Quantification (AAQ)

Tool A explicitly states 'FDA-clearance: yes,' 'HIPAA compliant: yes,' and 'has_baa: yes (implied by hipaa compliance and healthcare data handling),' along with 'Cloud-based (utilizes AWS for cloud infrastructure)' and 'Seamless integration with Electronic Health Records (EHRs).' Tool B uses 'likely, contact vendor' for HIPAA compliance and BAA, introducing a slight ambiguity for enterprise buyers. Tool A's explicit declarations and EHR integration demonstrate a higher degree of enterprise readiness.

Innovation

Bunkerhill Abdominal Aortic Quantification (AAQ)

Tool A's description highlights 'The generative AI platform for clinical reasoning and action' and 'AI-powered reasoning across structured and unstructured patient data,' suggesting a more advanced and intelligent AI approach beyond just quantitative measurements. While Tool B is an 'AI-powered quantitative imaging platform,' its description does not explicitly detail similar advanced AI capabilities like generative AI or clinical reasoning.

Support & Docs

Tie

Neither the provided structured facts nor a general web search yielded specific information regarding the availability, scope, or quality of support services or documentation for either Bunkerhill Abdominal Aortic Quantification (AAQ) or AI-CVD. Therefore, it is not possible to distinguish between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill Abdominal Aortic Quantification (AAQ)	AI-CVD
Product Name	Bunkerhill Abdominal Aortic Quantification (AAQ)	AI-CVD
Company	BunkerHill Health	HeartLung Corporation
Description	Bunkerhill Abdominal Aortic Quantification (AAQ) is the first FDA-cleared AI to automate abdominal aortic diameter quantification on contrast and non-contrast CT scans, enabling early aneurysm detection and streamlined follow-up within the Carebricks platform.	AI-CVDu00ae is an FDA-cleared, AI-powered quantitative imaging platform from HeartLung Corporation that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks.
Key Features (Abdominal Aortic Quantification)	Automated abdominal aortic diameter quantification on contrast and non-contrast CT scans; Opportunistic screening for silent aneurysms from routine CTs; Detection of interval growth in aortic measurements beyond configured thresholds.	Aorta and pulmonary artery sizing
Key Features (Cardiovascular Screening beyond Aorta)	Not specified	Coronary Artery Calcium (CAC) scoring; Aortic wall, aortic valve, and mitral valve calcium analysis; Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle); Epicardial fat volumetry
Integration	Integration with Carebricks platform for automated follow-up workflows; Seamless integration with Electronic Health Records (EHRs)	Not specified
Specialties	Cardiology, Radiology, Vascular Surgery	Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill Abdominal Aortic Quantification (AAQ) and AI-CVD.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary differences in the conditions screened by Bunkerhill AAQ and AI-CVD?

Bunkerhill Abdominal Aortic Quantification (AAQ) specifically focuses on automating abdominal aortic diameter quantification for early aneurysm detection. In contrast, AI-CVD offers broader opportunistic screening for cardiovascular and multisystem diseases, including Coronary Artery Calcium (CAC) scoring, aortic and mitral valve calcium analysis, cardiac chamber volumetry, and epicardial fat volumetry.

What types of CT scans can each tool analyze?

Bunkerhill AAQ is designed to automate abdominal aortic diameter quantification on both contrast and non-contrast CT scans. AI-CVD performs opportunistic screening using existing chest and abdominal CT scans, without requiring additional imaging, radiation, or contrast.

How do these tools integrate into existing clinical workflows and follow-up processes?

Bunkerhill AAQ integrates with the Carebricks platform to enable automated follow-up workflows, guideline-based surveillance, and seamless integration with Electronic Health Records (EHRs). AI-CVD emphasizes opportunistic screening from existing CT scans with no additional workflow disruption, but specific details on automated follow-up integration are not explicitly provided beyond early detection.

What specific quantitative measurements do these tools provide?

Bunkerhill AAQ provides automated abdominal aortic diameter quantification and detects interval growth in aortic measurements beyond configured thresholds. AI-CVD offers automated CT-derived anatomical and density-based measurements, including Coronary Artery Calcium (CAC) scoring, aortic wall, aortic valve, and mitral valve calcium analysis, cardiac chamber volumetry, and epicardial fat volumetry.

What is the scope of AI-powered reasoning and automation offered by each tool?

Bunkerhill AAQ features AI-powered reasoning across structured and unstructured patient data and automates appropriate next steps and actions within clinical workflows. AI-CVD focuses on AI-powered quantitative imaging for opportunistic screening and early detection of various diseases, but does not explicitly detail AI-powered reasoning for next steps or unstructured data analysis.